Role Of Marma Therapy In The Treatment Of Insomnia

A CLINICO ANATOMICAL STUDY OF MARMA THERAPY ON SHANKA AND SEEMANTHA MARMA IN THE MANAGEMENT OF NIDRANASHA( PRIMARY INSOMNIA) - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068948

Enrollment

Registered

2024-06-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G470- Insomnia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having sleep disturbance for atleast 1 month will be taken for this trial Age group 17-70year Patients irrespective of sex, socio-economic status, education and religion were considered Patients with Athens insomnia scale is more than 6 were selected Provided informed consent

Exclusion criteria

Exclusion criteria: Patients with major psychiatric illness like schizophrenia, epilepsy etc were not registered Age group below 17 and above 70 years Patients having chronic illness like asthma, malignancies breathing related sleep disorders Patients under drug abuse or other medication which are known to cause drowsiness Participation in another clinical trial Unwilling persons

Design outcomes

Primary

Measure	Time frame
Marma Therapy will be effective to alleviate patient suffering from NidranashaTimepoint: 30 Days	—

Secondary

Measure	Time frame
Marma Therapy will be provide a safe & effective treatmentTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDrShyoram Sharma

Post Graduate Institute of Ayurveda

rajanakhila32@gmail.com9633870125

Outcome results